Recent National Institutes of Health (NIH) research has shown some older medication therapies, like aspirin, a type of non-steroidal anti-inflammatory drug (NSAID), may have other health benefits.
Aspirin and other NSAIDs are known to have anti-inflammatory effects by inhibiting COX (cyclooxygenase) enzymes. These enzymes are pivotal in the inflammatory process, which is the body's normal reaction to an injury or disease. Long-term inflammation is linked to other diseases
One way that you can support people living with scleroderma for Scleroderma Awareness Month is to take part in your local Stepping Out to Cure Scleroderma event.
These walk and run events are held all over the United States by Scleroderma Foundation chapters and support groups. They are a fun, family-friendly event. Many walks are still happening this June and throughout the rest of the year so find an event near you.
If you don't find a walk in your state or town or you aren't physically able to participate, you can still support the cause. Join our World Scleroderma Day virtual event, where you can sign-up to fundraise. Create a team and ask your family and friends to join your fundraising effort.
Lace up your shoes to help us find a cure!
12% of Scleroderma Patients Have PH
Did you know up to 12% of scleroderma patients also have pulmonary hypertension (PH)? Learn more information about this from medical professionals and have the opportunity to network with other patients and caregivers at the Pulmonary Hypertension Association's PHA on the Road.
PHA on the Road is a FREE all-day program taking place in St. Paul, MN; Providence, RI; Portland, OR; and Pittsburgh, PA.
Actelion Pharmaceuticals US, Inc. and the ENTELLIGENCE Steering Committee recognized four young researchers and their mentors this year for their efforts in advancing research in pulmonary vascular pathobiology. Each researcher will receive a 12-month mentored grant of up to $100,000, funded through the Actelion-supported ENTELLIGENCE program.
The announcement was made at a recent award luncheon held in Washington, DC during the time of the American Thoracic Society’s annual meeting. The recipients of the 2017 awards gave an overview of their proposed work during the luncheon.
Disclaimer: The Scleroderma Foundation in no way
endorses any drugs, treatments, clinical trials, or studies reported in the eLetter. Information is
provided to keep the readers informed. Because the manifestations and severity of scleroderma vary among individuals, personalized medical management is essential. Therefore, it is strongly recommended that all drugs and treatments be discussed with the reader’s physician(s) for proper evaluation and treatment.
The Scleroderma Foundation is a qualified national nonprofit operating under 501(c)(3) status. The foundation’s federal tax identification number is 52-1375827. Our primary goal is to raise funds for our three-fold mission of support, education and research. The foundation has 20 active chapters and 160 support groups across the country.